Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019	Dec. 31, 2019
Cash flow from operating activities
Net Income (Loss)	$ (1,665,899)	$ (1,380,943)	$ (3,593,764)	$ (3,327,906)	$ (6,060,751)
Adjustment to reconcile comprehensive income/(loss) to net cash used in operating activities
Depreciation and amortization	533,863	562,570	1,093,486	1,123,587
Non cash expenses			6,117
Provision for Preference dividend			215,670	211,939
Changes in fair value of warrants		(388,552)		61,715
Stock, option, restricted stock unit and warrant expense			34,642	490,175
Foreign exchange translation adjustment			(20,149)	573
Provision for Income taxes ( net off deferred income taxes)	17,485	16,590	39,377	(14,621)
Loss on sale of fixed assets			21,611
Increase (decrease) in:
Accounts receivable			(910,430)	(673,381)
Other current assets			(103,393)	(1,388)
Increase (decrease) in:
Accounts payable and accrued expenses			366,713	655,151
Net cash provided by (used in) operating activities			(2,864,426)	(1,474,156)	(2,453,123)
Cash flow from investing activities
Purchase of fixed assets			(39,969)	(27,698)
Acquisition consideration				(200,000)
Net cash used in investing activities			(39,969)	(227,698)
Cash flow from financing activities
Proceeds from bank loan and convertible notes, net			2,835,685	(191,762)
Proceeds from issuance of common shares, net			1,725,000	2,123,425
Net cash provided by financing activities			4,560,685	1,931,663
Net increase (decrease) in cash and cash equivalents			1,656,291	229,809
Cash and cash equivalents as at beginning of the period			431,400	1,371,331	1,371,331
Cash at the end of the period	$ 2,087,691	$ 1,601,140	$ 2,087,691	$ 1,601,140	$ 431,400